Nasacort and Nasonex are both allergy nasal sprays that contain drugs called corticosteroids. With allergies, the body’s immune system responds to an allergen, or trigger. This causes symptoms such as ...

WHITEHOUSE STATION, N.J. — Merck announced that the U.S. District Court for the District of New Jersey ruled against the company in a patent infringement suit against Canada-based drug maker Apotex.

The FDA’s Division of Drug Marketing, Advertising and Communications has issued untitled letters of violation to Schering-Plough for its Nasonex nasal spray, and to GlaxoSmithKline for its Flonase ...

Merck, Sharp & Dohme Corp. has filed a second suit to halt plans by Apotex Inc. for a generic version of Merck's popular nasal spray, Nasonex, after the company's previous patent infringement suit in ...

Nasonex is currently approved in more than 100 countries and is anticipated to be available in Japan this fall.Schering-Plough Corp. (NYSE: SGP) of Kenilworth said today that its Japanese unit has ...

June 15 (Reuters) - Merck & Co, Inc lost a patent infringement lawsuit against Apotex Inc on Friday over Apotex's plans to market a generic version of the nasal allergy spray Nasonex. Sign up here.

Last week, on Friday, June 15, 2012, Merck (NYSE: MRK) announced the U.S. District Court for the District of New Jersey (Judge Peter G. Sheridan) ruled against the company on the issue of patent ...

With spring allergies in the air, two prescription-products-gone-over-the-counter recently – Astepro and Nasonex -- have sprung creative campaigns. Surrounded by flowers, and clothed and posed as if ...

DTC TV prescription drug ads featuring an animated bee and a talking beaver were most recalled by consumers during 2007, according to ad performance tracking firm IAG Research. A 30-second spot ...

With sales just shy of $1.3 billion in 2011, Nasonex allergy spray is Merck's fifth-best-selling drug. The rebuff comes at a tough time for the drugmaker, however. In August, it loses loses patent ...